Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shoenut, J. P.
Right arrow Articles by Kryger, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shoenut, J. P.
Right arrow Articles by Kryger, M. H.
(Chest. 1994;106:738-741.)
© 1994 American College of Chest Physicians

The Effect of Nasal CPAP on Nocturnal Reflux in Patients With Aperistaltic Esophagus

J. Patrick Shoenut 1; Paul Kerr M.D.2; Allan B. Micflikier M.D.1; Yoshihiro Yamashiro M.D.1; and Meir H. Kryger M.D., F.C.C.P.1

1 From the Department of Medicine, St. Boniface General Hospital and the University of Manitoba Winnipeg, Canada
2 From the Department of Surgery, St. Boniface General Hospital and the University of Manitoba Winnipeg, Canada

It has been shown that nasal continuous positive airway pressure (nasal CPAP) significantly reduces nocturnal reflux both in patients with sleep apnea and in patients without sleep apnea but consistent abnormal nocturnal reflux. The mechanism by which CPAP is thought to reduce reflux includes the elevation of the resting lower esophageal sphincter (LES) pressure. In this study, we tested the effect of nasal CPAP in two groups of patients with aperistaltic esophagus but with different resting LES pressure. Seven patients with scleroderma esophagus and six patients treated for achalasia were tested over a 48-h period. On the first night, the patients were untreated; on the second night, both groups received applied nasal CPAP at 8 cm H2O pressure. The percentage of time the pH <4.0, the number of reflux events >5 min, and the length of the longest reflux event were all significantly reduced in the patients with achalasia (p<0.03), but not in the scleroderma group (p>0.20). These results suggest that a residual resting LES pressure greater than that demonstrated by patients with scleroderma (>10 mm Hg) may be necessary for nasal CPAP to affect nocturnal reflux.

Key Words: achalasia • gastroesophageal reflux • nasal CPAP • scleroderma • 24-h esophageal pH monitoring

Submitted on December 2, 1993
Accepted on February 3, 1994




This article has been cited by other articles:


Home page
ChestHome page
M. Tawk, S. Goodrich, G. Kinasewitz, and W. Orr
The effect of 1 week of continuous positive airway pressure treatment in obstructive sleep apnea patients with concomitant gastroesophageal reflux.
Chest, October 1, 2006; 130(4): 1003 - 1008.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
B. T. Green, W. A. Broughton, and J. B. O'Connor
Marked Improvement in Nocturnal Gastroesophageal Reflux in a Large Cohort of Patients With Obstructive Sleep Apnea Treated With Continuous Positive Airway Pressure
Arch Intern Med, January 13, 2003; 163(1): 41 - 45.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. S. Irwin and J. M. Madison
The Diagnosis and Treatment of Cough
N. Engl. J. Med., December 7, 2000; 343(23): 1715 - 1721.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the American College of Chest Physicians.